Federal Primary Care’s Future: Investor Guide to Tech Platforms

The field of primary care investment is undergoing a deep transformation, driven by the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s new Making Care Primary (MCP) model. This ambitious initiative, designed to be the future of federal primary care strategy, offers a structured glide path from traditional fee-for-service arrangements to prospective capitation. For early-stage and growth equity investors in primary care and digital health, understanding MCP’s phased approach is critical to evaluating the cash flow trajectories and growth potential of technology-enabled primary care platforms.

The Strategic Shift: Making Care Primary and its Tracks

Launched in July 2024 across eight states (Colorado, Massachusetts, Minnesota, New Jersey, New Mexico, New York, North Carolina, and Washington), the Making Care Primary model signals a decisive move towards value-based care in primary care. This initiative, supported by organizations like the American Academy of Family Physicians (AAFP), aims to strengthen primary care infrastructure, improve care coordination, and in the end enhance health outcomes while reducing costs. Unlike previous models, MCP is designed with three progressive tracks, each escalating the level of financial risk and operational complexity for participating practices. This structured progression provides a clear roadmap for primary care providers to evolve their business models, moving from foundational value-based care capabilities to advanced population health management.

Track 1: Building Foundational Capabilities for Value

Track 1 of the MCP model is designed for practices with limited experience in value-based care, offering a gentle introduction to risk while providing resources for capability building. In this track, practices continue to operate largely under fee-for-service but receive prospective payments to support care transformation activities. The focus here is on establishing core competencies: enhanced care management, care coordination, health equity initiatives, and data reporting. For technology-enabled primary care platforms, success in Track 1 hinges on providing tools that facilitate these foundational elements. Key technological requirements include:

• Strong EHR Integration: Smooth bidirectional data flow between the platform and existing electronic health record (EHR) systems is paramount for efficient care coordination and reporting.
• Basic Risk Stratification: Tools that can identify high-risk patients based on claims data and simple clinical parameters are essential for targeted care management.
• Patient Engagement Portals: Secure platforms for patient communication, education, and remote monitoring lay the groundwork for proactive care.
• Reporting and Analytics: Capabilities to track quality metrics, utilization patterns, and early cost insights are vital for demonstrating progress and informing care redesign.

Investors should scrutinize platforms’ interoperability capabilities and their ability to demonstrate tangible improvements in care coordination metrics, even without significant downside risk. Platforms that can quickly onboard practices and show early wins in patient engagement and data capture will be well-positioned.

Track 2: Embracing Performance-Based Payments and Shared Savings

Track 2 marks a significant step towards value-based care, introducing performance-based payments and shared savings opportunities. Practices in this track are expected to demonstrate improved quality and cost efficiency, taking on a modest level of upside risk. The shift requires more sophisticated data analytics and proactive population health management strategies. Technology requirements for Track 2 become more demanding:

• Advanced Risk Stratification: Platforms must offer predictive analytics to identify patients at risk of adverse events or high utilization, enabling proactive interventions. This moves beyond simple claims-based risk scores to incorporate social determinants of health (SDOH) and real-time clinical data.
• Care Gap Closure Tools: Automated identification of care gaps (e.g., missed screenings, uncontrolled chronic conditions) and workflows to address them are important for quality improvement.
• Referral Management: Integrated systems to manage specialist referrals, track patient adherence, and ensure closed-loop communication become critical for cost control and care continuity.
• Enhanced Data Analytics: Complete dashboards that track performance against quality benchmarks, total cost of care, and patient outcomes are essential for optimizing practice operations and demonstrating value.

Companies like Oak Street Health and Agilon Health, while operating at a more advanced stage of value-based care, exemplify the kind of data-driven operational excellence that Track 2 participants will need to cultivate. Their ability to manage complex patient populations and drive cost efficiencies through integrated care models provides a benchmark. Investors should look for platforms that can show demonstrable improvements in quality metrics and early signs of cost reduction within pilot programs or existing client cohorts.

Track 3: Prospective Capitation and Advanced Population Health Management

Track 3 represents the pinnacle of the MCP model, transitioning practices to prospective capitation payments and requiring them to assume greater financial risk, including potential downside risk. This track demands a fully integrated, data-driven approach to population health management, where primary care practices are responsible for the total cost of care for their attributed patient panel. For technology-enabled primary care platforms, Track 3 necessitates a complete suite of advanced capabilities:

• Full-Stack Population Health Management: This includes sophisticated predictive modeling, real-time data integration from diverse sources (EHRs, claims, wearables, SDOH), and strong care coordination tools that span the entire care continuum.
• Financial Performance Monitoring: Tools that provide granular insights into utilization, cost drivers, and revenue projections under capitation are indispensable for financial sustainability. This includes the ability to model different risk adjustment methodologies.
• Provider Performance Management: Analytics that help optimize physician panel sizes, identify high-performing providers, and support continuous quality improvement initiatives are vital.
• Integrated Behavioral Health and Social Support: Platforms must facilitate smooth integration of behavioral health services and connections to community resources, recognizing their critical impact on overall health and cost.

The transition to prospective capitation fundamentally alters the cash flow dynamics for primary care enablers. Platforms that can effectively manage risk, drive significant AI healthcare cost reduction, and demonstrate superior outcomes-based AI health will command premium valuations. Investors should seek evidence of AI health financial performance, specifically how platforms enable practices to thrive under capitation by reducing avoidable utilization and improving chronic disease management. This requires strong, peer-reviewed outcomes data, a standard that few AI health platforms currently meet.

Evaluating Tech-Enabled Platforms in the MCP Era

For investors, the MCP model provides a clear framework for evaluating technology-enabled primary care platforms. The key is to assess a platform’s readiness and capability to support practices through each progressive track.

Key Investor Due Diligence Questions:

• Interoperability: How deeply and smoothly does the platform integrate with diverse EHR systems and other data sources? Can it pull and push data effectively to support care coordination and reporting across different practice environments?
• Risk Management & Prediction: What is the sophistication of the platform’s risk stratification capabilities? Does it use AI to predict future health events and costs, and is this predictive power validated?
• Outcomes Data & Financial Performance: Does the platform have peer-reviewed evidence demonstrating its impact on clinical outcomes, patient satisfaction, and, importantly, financial performance (e.g., reduced hospitalizations, lower total cost of care)? This is the ultimate differentiator for value-based care AI. Example of peer-reviewed digital health outcomes
• Scalability & Support: Can the platform effectively onboard and support primary care practices at various stages of their value-based care journey, from nascent to advanced capitation models?
• Regulatory Alignment: Is the platform designed with an understanding of federal models like MCP, and can it adapt to evolving regulatory requirements and reporting needs?

The Making Care Primary model is not just another federal initiative. It is a fundamental reorientation of primary care delivery and payment. For investors, understanding its nuances and the technological demands of each track will be paramount in identifying the next generation of successful primary care platforms that can genuinely drive AI healthcare cost reduction and deliver superior outcomes. CMS Innovation Center official MCP model details The future of primary care investment lies with those platforms that can demonstrably enable practices to thrive under increasing risk and accountability.